ALEXANDRIA, Va.–(BUSINESS WIRE)–Zeta Surgical, Inc. (“ZETA”), a medical technology company developing image-guided navigation and robotic systems for brain surgery and neuromodulation, today announced the launch of its collaboration with the Defense Advanced Research Projects Agency (DARPA) in support of the Phase 3 SPARC-TMS clinical study. The program will assess robotic, neuronavigated transcranial magnetic stimulation (TMS) administered in a single outpatient day for patients experiencing
